KLEBSIELLA PNEUMONIAE INFECTION: CLINICAL FEATURES AND OUTCOME AT HOSPITAL FOR TROPICAL DISEASES FROM 2020 TO 2021
Main Article Content
Abstract
Background: Klebsiella pneumoniae infections represent an important health concern, which involves diverse clinical features and high mortality. A deep understanding of the diversity of the clinical presentations caused by K. pneumoniae is expected to a better treatment strategies implementation against this important pathogen. Objectives: To describe the clinical features and identify risk factors for mortality in patents with community and hospital acquired K. pneumoniae infection. Methods: A observational study of patients admitted to Hospital for Tropical Diseases from January 2020 to August 2021 had a positive culture of K. pneumoniae from at least one laboratory sample. Results: In 190 patients with K. pneumoniae infection that were recruited, community-acquired infection accounted for 66,8%. The mean age was 53,3±16,9 and 59,5% of the sample was male. 75,3% patients had prior chronic underlying diseases. All of the hospital-acquired infections were single-organ infection, with pneumonia accounted for 60,3%. Community-acquired infection represented with some distinct clinical features, including liver abscess (22,0%), meningitis (7,1%), and multi-organ infections (8,7%). The overall mortality was 22,9%. Factors related to increase mortality were consciousness alterations (OR 10,02 (2,7-37,0), renal impairment (OR 5,8 (2,2-15,5), and hospital-acquired infection (OR 3,96 (1,1-13,1). While urinary tract infection was associated with lower mortality ((OR 0,06 (0,01-0,40)). Conclusion: The study showed differences in clinical presentations due to K. pneumoniae infections between community and hospital-acquired infection. In addition to multi-drug resistant strains causing hospital-acquired infection, distinct clinical features of community-acquired hypervirulent K. pneumoniae should be noticed.
Article Details
Keywords
K. pneumoniae, community-acquired infection, hospital-acquired infection.
References


2. Phu VD, Wertheim HF, Larsson M, et al. Burden of Hospital Acquired Infections and Antimicrobial Use in Vietnamese Adult Intensive Care Units. PLoS One. 2016;11(1):e0147544.doi: 10.1371/journal.pone.0147544


3. Paczosa MK, Mecsas J. Klebsiella pneumoniae: Going on the Offense with a Strong Defense. Microbiol Mol Biol Rev. 2016;80(3):629-61.doi: 10.1128/MMBR.00078-15


4. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3): 128-40.doi: 10.1016/0196-6553(88)90053-3


5. Trần Viết Tiến, Nguyễn Thị Phương. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và một số yếu tố tiên lượng nặng ở bệnh nhân nhiễm khuẩn huyết do Klebsiella (01-2015 đến 06-2016). Tạp Chí Y - Dược Học Quân Sự. 2018;(9):57-63.

6. Meatherall BL, Gregson D, Ross T, Pitout JD, Laupland KB. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med. 2009;122(9):866-73.doi: 10.1016/ j.amjmed.2009.03.034


7. Kang CI, Kim SH, Bang JW, et al. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci. 2006;21(5):816-22.doi: 10.3346/jkms.2006.21.5.816


8. Juan CH, Chuang C, Chen CH, Li L, Lin YT. Clinical characteristics, antimicrobial resistance and capsular types of community-acquired, healthcare-associated, and nosocomial Klebsiella pneumoniae bacteremia. Antimicrob Resist Infect Control. 2019; 8(1).doi: 10.1186/s13756-018-0426-x


9. Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev. 2019;32(3):doi: 10.1128/CMR.00001-19


10. Lee HC, Chuang YC, Yu WL, et al. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia. J Intern Med. 2006;259(6): 606-14.doi: 10.1111/j.1365-2796.2006.01641.x

